Serum Anti-interferon-γ Autoantibody Titer as a Potential Biomarker of Disseminated Non-tuberculous Mycobacterial Infection.

Kazutaka YoshizawaAmi AokiKenjiro ShimaYoshinari TanabeToshiyuki KoyaTakashi HasegawaToshiaki KikuchiTakuro Sakagami

Published in: Journal of clinical immunology (2020)

Despite the improvement in the pathological condition via treatment, the patients' sera maintained neutralizing capacity against IFN-γ. Antibody titer fluctuated over the course of the disease and exhibited potential as a biomarker for judgment of the disease state.

Keyphrases

end stage renal disease
ejection fraction
dendritic cells
chronic kidney disease
newly diagnosed
mycobacterium tuberculosis
peritoneal dialysis
prognostic factors
patient reported outcomes
risk assessment
combination therapy
zika virus
dengue virus
human health